profit from every $100 of sales.
$0$100
Check-Cap Ltd. Ordinary Share
$2.19+8.96% today
+41.3% in 1 year
1-year low $1.301-year high $14.00
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $8.09 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Check-Cap Ltd. Ordinary Share sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with $4.14 million of profit last year.
SalesProfit
Check-Cap Ltd. Ordinary Share vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Check-Cap Ltd. Ordinary Share | 8.1× · No profit yet | ||
 Illumina | 37.9× · Expensive | ||
 Labcorp Holdings | 34.5× · Expensive | ||
 Quest Diagnostics | 28.8× · Fair price | ||
 Guardant Health | No profit yet |
AI analysis
An AI analyst reads Check-Cap Ltd. Ordinary Share's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -20 | -18 | -9 | -2 | |
| -19 | -17 | -25 | 4 | |
| -19 | -18 | -25 | 4 | |
| -3.37 | -3.00 | -4.30 | 0.66 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 45 | 25 | 0 | 7 |
| Cash | 4 | 9 | 0 | 0 |
| Total debt | 1 | 0 | 0 | 0 |
| Total liabilities | 4 | 1 | 2 | 4 |
| 41 | 24 | -1 | 3 | |
| 6 | 6 | 6 | 6 | |
| -35.7% | -58.5% | – | 99.0% | |
| -46.3% | -74.2% | 1,734.4% | 120.5% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -19 | -17 | -8 | -0 | |
| 0 | 0 | – | – | |
| -19 | -17 | -8 | -0 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 1 | -0 | 0 | -0 |
Valuation
- 8.1×
- –
- –
- 2.6×
- –
- –
- 1.9×
- -0.1%
- 12.4%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -68.7%
- 376.3%
- 416.7%
- 55.3%
- -69.0%
- –
Growth
- –
- –
- +99.4%
- –
- +2.4%
Financial health
- 0.0×
- 0.00
- 0.2%
- -12.8×
- 0.05
- 0.05
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 3%of 958
Bottom 21%of 888
Top 6%of 600
Bottom 38%of 987
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
28No pass
Benjamin Graham
51No pass
Philip Fisher
40No pass
Peter Lynch
62Pass
Joel Greenblatt
29No pass
Charlie Munger
27No pass
Terry Smith
18No pass
Questions about Check-Cap Ltd. Ordinary Share
Is Check-Cap Ltd. Ordinary Share a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Check-Cap Ltd. Ordinary Share AI analysis
What does Check-Cap Ltd. Ordinary Share do?
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel. It is in Medical - Diagnostics & Research.
Does Check-Cap Ltd. Ordinary Share pay a dividend?
No. Check-Cap Ltd. Ordinary Share does not pay a dividend at the moment.
Is Check-Cap Ltd. Ordinary Share stock halal?
Yes. Check-Cap Ltd. Ordinary Share passes our halal screen: its business is permitted and its debt is under 0.1% of its market value, under the 30% limit. How we check
How has Check-Cap Ltd. Ordinary Share stock done over the past year?
Up 41.3% over the past twelve months, to $2.19. It traded between $1.30 and $14.00 and is 84.4% below its high.
Who are Check-Cap Ltd. Ordinary Share's competitors?
The largest listed companies in the same industry are Illumina, Labcorp Holdings, Quest Diagnostics and Guardant Health. The peers table on this page compares their profit, growth and price with Check-Cap Ltd. Ordinary Share's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.